{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:53:17Z","timestamp":1787064797562,"version":"build-2736575974"},"reference-count":45,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>\n                    Two phase III studies with tamsulosin, a selective \u03b1\n                    <jats:sub>1A<\/jats:sub>\n                    -adrenergic receptor antagonist, were conducted to evaluate the safety and efficacy of the standard treatment doses of 0.4 mg\/day and 0.8 mg\/day in patients with symptoms of benign prostatic hyperplasia (BPH). These large-scale clinical trials were the first to include extensive testing for possible drug-induced orthostatic hypotension (OH). The frequency of positive orthostatic tests and magnitude of vital sign changes were compared among tamsulosin and placebo-treated groups. The results indicate that tamsulosin up to 0.8 mg\/day does not induce higher risk of OH than that of placebo. Data from post-marketing surveillance (PMS) studies of tamsulosin indicate that the incidence of hypotension and syncope is extremely low in community-dwelling elderly men treated for BPH. From the results of the phase III studies, PMS studies and an active-controlled clinical pharmacology study, we conclude that the orthostatic test is a useful and convenient method to evaluate the risk of OH and syncope during the investigational stage\n                  <\/jats:p>","DOI":"10.1177\/147323000102900312","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T14:22:28Z","timestamp":1361974948000},"page":"236-251","source":"Crossref","is-referenced-by-count":16,"title":["Review of Orthostatic Tests on the Safety of Tamsulosin, a Selective \u03b1\n                    <sub>1A<\/sub>\n                    -Adrenergic Receptor Antagonist, Shows Lack of Orthostatic Hypotensive Effects"],"prefix":"10.1177","volume":"29","author":[{"given":"K","family":"Yasukawa","sequence":"first","affiliation":[{"name":"Yamanouchi Pharmaceutical Co. Ltd, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Swarz","sequence":"additional","affiliation":[{"name":"International Pharmaceutical Consultants, Inc., New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ito","sequence":"additional","affiliation":[{"name":"Ito and Associates, Inc., New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2001,6,1]]},"reference":[{"key":"bibr1-147323000102900312","first-page":"318","volume":"43","author":"Garraway WM","year":"1993","journal-title":"Br J Gen Pract"},{"key":"bibr2-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(21)00963-0"},{"key":"bibr3-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35544-1"},{"key":"bibr4-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990220404"},{"key":"bibr5-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1994.tb09188.x"},{"key":"bibr6-147323000102900312","first-page":"181","volume":"4","author":"Miranda HF","year":"1994","journal-title":"Pharmacol Commun"},{"key":"bibr7-147323000102900312","first-page":"703","volume":"45","author":"Forray C","year":"1994","journal-title":"Mol Pharmacol"},{"key":"bibr8-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1995.tb07709.x"},{"key":"bibr9-147323000102900312","first-page":"129","volume":"29","author":"Chapple CR","year":"1996","journal-title":"Eur Urol"},{"key":"bibr10-147323000102900312","first-page":"155","volume":"29","author":"Chapple CR, Wyndaele JJ, Nordling J, Boeminghaus F, Ympa AF, Abrams P, on behalf of the European Tamsulosin Study Group","year":"1996","journal-title":"Eur Urol"},{"key":"bibr11-147323000102900312","first-page":"145","volume":"29","author":"Schulman CC, Cortvriend J, Jonas U, Lock TM, Vaage S, Speakman MJ, on behalf of the European Tamsulosin Study Group","year":"1996","journal-title":"Eur Urol"},{"key":"bibr12-147323000102900312","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199652060-00012"},{"key":"bibr13-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00126-5"},{"key":"bibr14-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00127-7"},{"key":"bibr15-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62386-3"},{"key":"bibr16-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39620-9"},{"key":"bibr17-147323000102900312","unstructured":"Data on file: Yamanouchi Europe BV, Elisabethhof 19, 2353 EW Leiderdorp, The Netherlands"},{"key":"bibr18-147323000102900312","unstructured":"Data on file: Yamanouchi Pharmaceutical Co. Ltd, 3-11 Nihonbashi-Honcho 2-chome, Chuoku, Tokyo 103-8411, Japan"},{"key":"bibr19-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199902000-00002"},{"key":"bibr20-147323000102900312","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.617"},{"key":"bibr21-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910053211407"},{"key":"bibr22-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.70.827.638"},{"key":"bibr23-147323000102900312","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1212\/WNL.45.1.6","volume":"45","author":"Mathias CJ","year":"1995","journal-title":"Neurology"},{"key":"bibr24-147323000102900312","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.713"},{"key":"bibr25-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90012-M"},{"key":"bibr26-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1042\/cs0690337"},{"key":"bibr27-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1159\/000282030"},{"key":"bibr28-147323000102900312","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199303030-00007"},{"key":"bibr29-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67240-9"},{"key":"bibr30-147323000102900312","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549020-00011"},{"key":"bibr31-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608223350801"},{"key":"bibr32-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80409-9"},{"key":"bibr33-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1159\/000052284"},{"key":"bibr34-147323000102900312","unstructured":"Minipress\u2122 (package insert), Pfizer Pharmaceuticals Inc., New York, NY, USA, October 1995"},{"key":"bibr35-147323000102900312","unstructured":"Hytrin\u2122 (package insert), Abbott Laboratories, Abbott Park, IL, USA, October 1996"},{"key":"bibr36-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1998.0810s1034.x"},{"key":"bibr37-147323000102900312","unstructured":"Cardura\u2122 (package insert), Pfizer Pharmaceuticals Inc., New York, NY, USA, June 1997"},{"key":"bibr38-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)36966-5"},{"key":"bibr39-147323000102900312","unstructured":"Data on file: Yamanouchi Pharmaceutical Co. Ltd. A double-blind, single- and multiple-dose study to assess the bioavailability and safety\/tolerance of tamsulosin (YM617) in the target population under fasted and two fed conditions (in-house report)"},{"key":"bibr40-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1984.00350170203031"},{"key":"bibr41-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1470"},{"key":"bibr42-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00205.x"},{"key":"bibr43-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1159\/000019639"},{"key":"bibr44-147323000102900312","first-page":"289","volume":"29","author":"Na YJ, Guo YL, Gu FL, for the Chinese Tamsulosin Study Group","year":"1998","journal-title":"J Med"},{"key":"bibr45-147323000102900312","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00546.x"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/147323000102900312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/147323000102900312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:42:44Z","timestamp":1777459364000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/147323000102900312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1177\/147323000102900312"],"URL":"https:\/\/doi.org\/10.1177\/147323000102900312","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}